1. Home
  2. BREA vs ENSC Comparison

BREA vs ENSC Comparison

Compare BREA & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BREA
  • ENSC
  • Stock Information
  • Founded
  • BREA 2022
  • ENSC 2003
  • Country
  • BREA Ireland
  • ENSC United States
  • Employees
  • BREA N/A
  • ENSC N/A
  • Industry
  • BREA Services-Misc. Amusement & Recreation
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • BREA Consumer Discretionary
  • ENSC Health Care
  • Exchange
  • BREA Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • BREA 8.7M
  • ENSC 7.9M
  • IPO Year
  • BREA 2023
  • ENSC N/A
  • Fundamental
  • Price
  • BREA $0.62
  • ENSC $5.62
  • Analyst Decision
  • BREA
  • ENSC
  • Analyst Count
  • BREA 0
  • ENSC 0
  • Target Price
  • BREA N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • BREA 47.0K
  • ENSC 58.0K
  • Earning Date
  • BREA 01-03-2025
  • ENSC 03-14-2025
  • Dividend Yield
  • BREA N/A
  • ENSC N/A
  • EPS Growth
  • BREA N/A
  • ENSC N/A
  • EPS
  • BREA N/A
  • ENSC N/A
  • Revenue
  • BREA $2,872,101.00
  • ENSC $4,421,404.00
  • Revenue This Year
  • BREA N/A
  • ENSC $89.78
  • Revenue Next Year
  • BREA N/A
  • ENSC N/A
  • P/E Ratio
  • BREA N/A
  • ENSC N/A
  • Revenue Growth
  • BREA 2338.69
  • ENSC 40.41
  • 52 Week Low
  • BREA $0.50
  • ENSC $2.12
  • 52 Week High
  • BREA $3.00
  • ENSC $16.95
  • Technical
  • Relative Strength Index (RSI)
  • BREA 36.60
  • ENSC 35.65
  • Support Level
  • BREA $0.60
  • ENSC $5.55
  • Resistance Level
  • BREA $0.68
  • ENSC $6.46
  • Average True Range (ATR)
  • BREA 0.05
  • ENSC 0.62
  • MACD
  • BREA -0.01
  • ENSC -0.13
  • Stochastic Oscillator
  • BREA 8.88
  • ENSC 7.31

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: